Canagliflozin as a Potential Preclinical Therapy for Tuberous Sclerosis Complex: Inhibition of Tsc2−/− Cell Proliferation via Cell Cycle Arrest and Mitochondrial Dysfunction

Ca inhibits <i>Tsc2</i> <sup>-/-</sup> cell proliferation through dual mechanisms of cell cycle arrest and mitochondrial impairment, demonstrating significant therapeutic potential for TSC-related lesions. These findings highlight Ca as a promising alternative to current mTOR inhibitors, warranting further investigation into its molecular targets and clinical applications.

Authors

Institutions

Publication Details

Journal
Drug Design Development and Therapy
Published
2025-12-01
DOI
https://doi.org/10.2147/dddt.s525749
Primary Topic
Tuberous Sclerosis Complex Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Canagliflozin as a Potential Preclinical Therapy for Tuberous Sclerosis Complex: Inhibition of Tsc2−/− Cell Proliferation via Cell Cycle Arrest and Mitochondrial Dysfunction

Kai Zheng, Qingyun Wei, K. X. Su, B. Liu et al.
Drug Design Development and Therapy
Tuberous Sclerosis Complex Research
article

Canagliflozin as a Potential Preclinical Therapy for Tuberous Sclerosis Complex: Inhibition of Tsc2−/− Cell Proliferation via Cell Cycle Arrest and Mitochondrial Dysfunction

Kai Zheng, Qingyun Wei, K. X. Su, B. Liu, Hongliang Gao, Jing Wu, Shuangchi Liu, Xing Peng, Yuqi Wang, Juan Ye, Tao Xu, Liming Gou, Yinjuan Zhao, Xiaoxiao Dai, Bin Xue
article en

Abstract

Ca inhibits <i>Tsc2</i> <sup>-/-</sup> cell proliferation through dual mechanisms of cell cycle arrest and mitochondrial impairment, demonstrating significant therapeutic potential for TSC-related lesions. These findings highlight Ca as a promising alternative to current mTOR inhibitors, warranting further investigation into its molecular targets and clinical applications.

Drug Design Development and TherapyVol. Volume 19
Wannan Medical College (CN), Nanjing University of Chinese Medicine (CN), Nanjing Forestry University (CN), Nanjing Children's Hospital (CN), Changzhou No.2 People's Hospital (CN), Nanjing Medical University (CN)
National Science Foundation, Jiangsu Commission of Health, National Natural Science Foundation of China, Government of Jiangsu Province, Nanjing Medical University, Natural Science Foundation of Xinjiang
Openalex Percentile: Top 53%
Tuberous Sclerosis Complex Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.